ArticleOncogene2024

TP53 somatic evolution in cervical liquid-based cytology and blood from individuals with and without ovarian cancer and BRCA1 or BRCA2 germline mutations.

Talayeh S Ghezelayagh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.